Business Description
Algorae Pharmaceuticals Ltd
ISIN : AU0000296022
Description
Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for under met medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. The products of the company comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. The company is conceptualized to be a potential treatment for dementia, including Alzheimer's disease, NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.94 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 37 | |||||
| 3-Year EPS without NRI Growth Rate | 20.6 | |||||
| 3-Year FCF Growth Rate | 20.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 88.49 | |||||
| 9-Day RSI | 53.4 | |||||
| 14-Day RSI | 41.8 | |||||
| 6-1 Month Momentum % | -38.41 | |||||
| 12-1 Month Momentum % | -57.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 17.94 | |||||
| Quick Ratio | 17.94 | |||||
| Cash Ratio | 17.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -40.7 | |||||
| Shareholder Yield % | -4.85 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -60.46 | |||||
| ROA % | -56.29 | |||||
| ROIC % | -7096.77 | |||||
| ROC (Joel Greenblatt) % | -17837.84 | |||||
| ROCE % | -63.48 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.5 | |||||
| EV-to-EBIT | -3.96 | |||||
| EV-to-EBITDA | -3.96 | |||||
| EV-to-FCF | -5.71 | |||||
| Earnings Yield (Greenblatt) % | -25.25 | |||||
| FCF Yield % | -12.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:LVCLF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Algorae Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.001 | ||
| Beta | -0.71 | ||
| Volatility % | 122.96 | ||
| 14-Day RSI | 41.8 | ||
| 14-Day ATR ($) | 0.00004 | ||
| 20-Day SMA ($) | 0.00425 | ||
| 12-1 Month Momentum % | -57.07 | ||
| 52-Week Range ($) | 0.0004 - 0.01028 | ||
| Shares Outstanding (Mil) | 1,687.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Algorae Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Algorae Pharmaceuticals Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Algorae Pharmaceuticals Ltd Frequently Asked Questions
What is Algorae Pharmaceuticals Ltd(LVCLF)'s stock price today?
The current price of LVCLF is $0.00. The 52 week high of LVCLF is $0.01 and 52 week low is $0.00.
When is next earnings date of Algorae Pharmaceuticals Ltd(LVCLF)?
The next earnings date of Algorae Pharmaceuticals Ltd(LVCLF) is .
Does Algorae Pharmaceuticals Ltd(LVCLF) pay dividends? If so, how much?
Algorae Pharmaceuticals Ltd(LVCLF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers